Neurocognitive substudy

Project no.: HIV-NAT 128.3

The neurocognitive sub-study in Encore1: A randomised, double‐blind, placebo‐controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus 2N(t)RTI in antiretroviral‐naïve HIV‐infected individuals over 96 weeks